CCL5 and influenza: We found that empagliflozin treatment decreased the expression of IL-6, CCL2, and CCL5 in BMDMs (Fig. 2A–C) and IL-6 and CCL2 in RAW264.7 macrophages (Fig. 2D, 2E) during influenza infection.